TCL Archive Varmus, Duke Ask IOM To Investigate Potti’s Scientific Work, Clinical Trials July 30, 2010
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Three Patients Evaluated For Gene Therapy; Revised Program Instructions Available November 30, 1990
